Showing results (111-120 of 651) with videos related to
Sort By:
Pageof 66
Kidney International|August 18, 2005
Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up studyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 30, 2009
Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trialKatrine J Schjoedt, Per K Christensen, Anders Jorsal, et al.Diabetes Care|September 5, 2020
Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 DiabetesAjenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, et al.Diabetes, Obesity & Metabolism|February 10, 2025
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trialsPeter Rossing, Malik Benamar, Alice Y Y Cheng, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2011
Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathyFrederik Persson, Julia B Lewis, Edmund J Lewis, et al.Amino Acids|March 9, 2011
Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuriaNaila Rabbani, Antonysunil Adaikalakoteswari, Kasper Rossing, et al.Diabetologia|August 18, 2016
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trialPeter Gæde, Jens Oellgaard, Bendix Carstensen, et al.Journal of Diabetes and Its Complications|October 23, 2016
Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatmentEmilie Hein Zobel, Bernt Johan von Scholten, Morten Lindhardt, et al.The Journal of Clinical Endocrinology and Metabolism|May 29, 2008
Elevated levels of high-molecular-weight adiponectin in type 1 diabetesHenrik Leth, Kristian K Andersen, Jan Frystyk, et al.Diabetologia|November 5, 2017
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohortIsabel Ferreira, Peter Hovind, Casper G Schalkwijk, et al.Pageof 66